Sundaresh Brahmasandra and Kalyan Handique, both 41, are serial entrepreneurs.
While attending the University of Michigan, the chemical engineering students co-founded medical device company HandyLab Inc. in 2000 to make bench-top devices for quick analysis of body fluids for use in research and the pharmaceutical industry.
Jeff Williams is one of Michigan’s most successful biotech entrepreneurs, with two of Michigan’s biggest exits—Accuri and Handylab—on his ledger. Now he’s hoping the third time’s a charm, too. Williams’ new molecular diagnostic start-up, NeuMoDx, just closed a $21 million Series B round in April.
NeuMoDx Molecular, Inc., a privately held diagnostics company developing a new platform for high throughput, low cost molecular testing, today announced completion of its Series B financing.